Published in Methods Enzymol on January 01, 1995
Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J (1998) 2.34
Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers. Clin Cancer Res (2012) 1.95
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. Mol Cancer (2014) 1.46
Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis. JAMA Surg (2015) 1.46
KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers. Br J Cancer (2013) 1.41
GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. Mol Cell Biol (2003) 1.18
Structure of ERA in complex with the 3' end of 16S rRNA: implications for ribosome biogenesis. Proc Natl Acad Sci U S A (2009) 1.11
TC21 causes transformation by Raf-independent signaling pathways. Mol Cell Biol (1996) 1.03
GTPase mechanism and function: new insights from systematic mutational analysis of the phosphate-binding loop residue Ala30 of Rab5. Biochem J (2000) 1.02
Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations. PLoS One (2013) 1.00
Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity. Proc Natl Acad Sci U S A (2000) 1.00
Phosphoinositol lipids bind to phosphatidylinositol 3 (PI3)-kinase enhancer GTPase and mediate its stimulatory effect on PI3-kinase and Akt signalings. Proc Natl Acad Sci U S A (2005) 0.99
PRL-1 protein promotes ERK1/2 and RhoA protein activation through a non-canonical interaction with the Src homology 3 domain of p115 Rho GTPase-activating protein. J Biol Chem (2011) 0.91
The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects. J Biol Chem (2017) 0.75
A gain-of-function germline mutation in Drosophila ras1 affects apoptosis and cell fate during development. PLoS One (2011) 0.75
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (1999) 20.34
The GTPase superfamily: conserved structure and molecular mechanism. Nature (1991) 19.64
The GTPase superfamily: a conserved switch for diverse cell functions. Nature (1990) 11.71
Proteins regulating Ras and its relatives. Nature (1993) 9.87
Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science (1997) 8.17
A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science (1987) 7.69
Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science (1998) 6.79
An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science (1996) 5.97
Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature (1990) 5.57
An essential role for Rac in Ras transformation. Nature (1995) 5.34
Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell (1992) 5.09
Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. J Virol (1980) 4.88
PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell (1990) 4.85
Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science (1988) 4.58
Inhibition by cAMP of Ras-dependent activation of Raf. Science (1993) 4.50
Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene (1998) 4.31
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat Med (1997) 3.64
The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature (1995) 3.61
A role for Rho in Ras transformation. Proc Natl Acad Sci U S A (1995) 3.59
Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J Biol Chem (2000) 3.28
Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet (1996) 3.08
Signal transduction. How receptors turn Ras on. Nature (1993) 3.01
A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20. EMBO J (1995) 2.99
Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci U S A (1988) 2.99
Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling. Mol Cell (2000) 2.95
Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med (1994) 2.81
Brefeldin A: the advantage of being uncompetitive. Cell (1999) 2.63
A model for the tertiary structure of p21, the product of the ras oncogene. Science (1985) 2.61
Interventions for promoting the initiation of breastfeeding. Cochrane Database Syst Rev (2005) 2.45
Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science (1994) 2.44
Genetic analysis of mammalian GAP expressed in yeast. Cell (1989) 2.44
Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation. Mol Cell Biol (1997) 2.44
Protein-tyrosine kinases regulate the phosphorylation, protein interactions, subcellular distribution, and activity of p21ras GTPase-activating protein. Mol Cell Biol (1991) 2.40
RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J (1993) 2.38
Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62. Cell (1992) 2.32
Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell (2000) 2.30
Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1. Cell (1991) 2.26
Molecular cloning and expression of a G25K cDNA, the human homolog of the yeast cell cycle gene CDC42. Mol Cell Biol (1990) 2.25
Insulin stimulation of gene expression mediated by p21ras activation. EMBO J (1991) 2.23
Signal transduction from multiple Ras effectors. Curr Opin Genet Dev (1997) 2.16
Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature (1991) 2.10
Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product. Science (1990) 2.09
GAP domains responsible for ras p21-dependent inhibition of muscarinic atrial K+ channel currents. Science (1992) 2.09
Analysis of RAS oncogene mutations in human lymphoid malignancies. Proc Natl Acad Sci U S A (1988) 2.01
Reconstitution of the Raf-1-MEK-ERK signal transduction pathway in vitro. Mol Cell Biol (1993) 1.99
Suppression of c-ras transformation by GTPase-activating protein. Nature (1990) 1.96
Ras p21 as a potential mediator of insulin action in Xenopus oocytes. Science (1987) 1.87
Activation of c-Raf-1 by Ras and Src through different mechanisms: activation in vivo and in vitro. EMBO J (1997) 1.83
Rac mediates growth factor-induced arachidonic acid release. Cell (1995) 1.83
Inhibition of protein synthesis stimulates the transcription of human beta-interferon genes in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1984) 1.78
Regulators and effectors of ras proteins. Annu Rev Cell Biol (1991) 1.76
Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C. J Biol Chem (2000) 1.69
ras p21 and GAP inhibit coupling of muscarinic receptors to atrial K+ channels. Cell (1990) 1.67
Biochemical and biological properties of the human N-ras p21 protein. Mol Cell Biol (1987) 1.65
SV40 T antigen binds specifically to a cellular 53 K protein in vitro. Nature (1981) 1.62
Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein. Nature (1985) 1.61
A role of PDGFRalpha in basal cell carcinoma proliferation. Proc Natl Acad Sci U S A (2001) 1.60
Breastfeeding promotion for infants in neonatal units: a systematic review and economic analysis. Health Technol Assess (2009) 1.59
Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO J (1995) 1.55
The COOH-terminal domain of the Rap1A (Krev-1) protein is isoprenylated and supports transformation by an H-Ras:Rap1A chimeric protein. Mol Cell Biol (1991) 1.52
A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene (1999) 1.49
Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res (1989) 1.49
The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene (1996) 1.48
Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor. Proc Natl Acad Sci U S A (1991) 1.46
Structural requirements for the interaction of p21ras with GAP, exchange factors, and its biological effector target. J Biol Chem (1993) 1.45
Cancer targets in the Ras pathway. Cold Spring Harb Symp Quant Biol (2005) 1.40
Comparison of oncolytic adenoviruses for selective eradication of oral cancer and pre-cancerous lesions. Gene Ther (2010) 1.39
The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase. J Biol Chem (1996) 1.36
Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis. J Biol Chem (1999) 1.36
N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome. Blood (1993) 1.32
Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015). Nat Med (2000) 1.31
E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines. Oncogene (2008) 1.30
Localization of the rap1GAP catalytic domain and sites of phosphorylation by mutational analysis. Mol Cell Biol (1992) 1.29
GTPase-activating protein SH2-SH3 domains induce gene expression in a Ras-dependent fashion. Mol Cell Biol (1992) 1.29
Inducible expression of amplified human beta interferon genes in CHO cells. Mol Cell Biol (1984) 1.26
Purification, characterization, and western blot analysis of human GTPase-activating protein from native and recombinant sources. J Biol Chem (1990) 1.23
T antigens of SV40-transformed cells. Cold Spring Harb Symp Quant Biol (1980) 1.20
Targets of B lymphocyte antigen receptor signal transduction include the p21ras GTPase-activating protein (GAP) and two GAP-associated proteins. J Immunol (1993) 1.19
Altered transforming growth factor signaling in epithelial cells when ras activation is blocked. J Biol Chem (1996) 1.16
ONYX-015: clinical data are encouraging. Nat Med (1998) 1.14
The Ras-related protein R-ras interacts directly with Raf-1 in a GTP-dependent manner. Biochem J (1994) 1.13
Regulation of epidermal growth factor receptor signaling by phosphorylation of the ras exchange factor hSOS1. J Biol Chem (1996) 1.13
Biochemical characterization of baculovirus-expressed rap1A/Krev-1 and its regulation by GTPase-activating proteins. Mol Cell Biol (1990) 1.13
Biochemical characterization of a novel KRAS insertion mutation from a human leukemia. J Biol Chem (1996) 1.12
Regulation of Ras-GAP and the neurofibromatosis-1 gene product by eicosanoids. Science (1991) 1.11
Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity. EMBO J (1993) 1.11
Purification of a plasma membrane-associated GTPase-activating protein specific for rap1/Krev-1 from HL60 cells. Proc Natl Acad Sci U S A (1991) 1.10
Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer. Clin Cancer Res (1999) 1.10
Rethinking research in breast-feeding: a critique of the evidence base identified in a systematic review of interventions to promote and support breast-feeding. Public Health Nutr (2007) 1.09
Replicating viruses as selective cancer therapeutics. Mol Med Today (1996) 1.09
Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells. J Biol Chem (1997) 1.08
Ras and the awd couple. Nature (1991) 1.08
p21rasGAP association with Fyn, Lyn, and Yes in thrombin-activated platelets. J Biol Chem (1992) 1.08
Ras p21: effects and regulation. Biochim Biophys Acta (1991) 1.07
N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood (1990) 1.07
Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. Cancer Res (1989) 1.05
Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCR. Leukemia (2008) 1.05
Ras regulation. NF is enough of GAP. Nature (1992) 1.04
Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells. J Natl Cancer Inst (2000) 1.04